Citadel Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-65,807
| Closed | -$17.1K | – | 6866 |
|
|
2023
Q1 | $17.1K | Sell |
65,807
-28,042
| -30% | -$7.29K | ﹤0.01% | 5423 |
|
|
2022
Q4 | $19.7K | Buy |
+93,849
| New | +$19.7K | ﹤0.01% | 5557 |
|
|
2022
Q3 | – | Sell |
-24,217
| Closed | -$17K | – | 7252 |
|
|
2022
Q2 | $17K | Buy |
24,217
+6,655
| +38% | +$4.67K | ﹤0.01% | 5754 |
|
|
2022
Q1 | $14K | Sell |
17,562
-41,000
| -70% | -$32.7K | ﹤0.01% | 6190 |
|
|
2021
Q4 | $59K | Buy |
58,562
+16,425
| +39% | +$16.5K | ﹤0.01% | 6116 |
|
|
2021
Q3 | $74K | Sell |
42,137
-22,506
| -35% | -$39.5K | ﹤0.01% | 5997 |
|
|
2021
Q2 | $118K | Buy |
64,643
+10,129
| +19% | +$18.5K | ﹤0.01% | 5889 |
|
|
2021
Q1 | $110K | Buy |
54,514
+37,219
| +215% | +$75.1K | ﹤0.01% | 5810 |
|
|
2020
Q4 | $37K | Sell |
17,295
-9,197
| -35% | -$19.7K | ﹤0.01% | 4909 |
|
|
2020
Q3 | $72K | Sell |
26,492
-4,106
| -13% | -$11.2K | ﹤0.01% | 4326 |
|
|
2020
Q2 | $121K | Buy |
30,598
+2,471
| +9% | +$9.77K | ﹤0.01% | 4204 |
|
|
2020
Q1 | $21K | Buy |
+28,127
| New | +$21K | ﹤0.01% | 4661 |
|
|
2019
Q4 | – | Sell |
-28,915
| Closed | -$20K | – | 5458 |
|
|
2019
Q3 | $20K | Buy |
28,915
+12,146
| +72% | +$8.4K | ﹤0.01% | 4511 |
|
|
2019
Q2 | $11K | Buy |
16,769
+4,168
| +33% | +$2.73K | ﹤0.01% | 4561 |
|
|
2019
Q1 | $35K | Buy |
12,601
+6,126
| +95% | +$17K | ﹤0.01% | 4325 |
|
|
2018
Q4 | $13K | Sell |
6,475
-220
| -3% | -$442 | ﹤0.01% | 4376 |
|
|
2018
Q3 | $31K | Sell |
6,695
-2,412
| -26% | -$11.2K | ﹤0.01% | 4076 |
|
|
2018
Q2 | $42K | Buy |
9,107
+300
| +3% | +$1.38K | ﹤0.01% | 3933 |
|
|
2018
Q1 | $63K | Buy |
8,807
+3,117
| +55% | +$22.3K | ﹤0.01% | 3712 |
|
|
2017
Q4 | $41K | Buy |
5,690
+3,656
| +180% | +$26.3K | ﹤0.01% | 3662 |
|
|
2017
Q3 | $17K | Buy |
2,034
+506
| +33% | +$4.23K | ﹤0.01% | 3548 |
|
|
2017
Q2 | $16K | Buy |
1,528
+58
| +4% | +$607 | ﹤0.01% | 3555 |
|
|
2017
Q1 | $17K | Buy |
+1,470
| New | +$17K | ﹤0.01% | 3562 |
|
|
2016
Q4 | – | Sell |
-3,426
| Closed | -$63K | – | 4364 |
|
|
2016
Q3 | $63K | Buy |
3,426
+2,740
| +399% | +$50.4K | ﹤0.01% | 3262 |
|
|
2016
Q2 | $7K | Buy |
686
+72
| +12% | +$735 | ﹤0.01% | 3300 |
|
|
2016
Q1 | $12K | Sell |
614
-1,338
| -69% | -$26.2K | ﹤0.01% | 3241 |
|
|
2015
Q4 | $52K | Buy |
1,952
+616
| +46% | +$16.4K | ﹤0.01% | 3431 |
|
|
2015
Q3 | $61K | Buy |
+1,336
| New | +$61K | ﹤0.01% | 3502 |
|
|
2015
Q1 | – | Sell |
-4,711
| Closed | -$178K | – | 4168 |
|
|
2014
Q4 | $178K | Buy |
4,711
+4,122
| +700% | +$156K | ﹤0.01% | 3112 |
|
|
2014
Q3 | $16K | Sell |
589
-46
| -7% | -$1.25K | ﹤0.01% | 3388 |
|
|
2014
Q2 | $19K | Buy |
635
+614
| +2,924% | +$18.4K | ﹤0.01% | 3282 |
|
|
2014
Q1 | $1K | Sell |
21
-2,253
| -99% | -$107K | ﹤0.01% | 3565 |
|
|
2013
Q4 | $94K | Buy |
2,274
+944
| +71% | +$39K | ﹤0.01% | 2654 |
|
|
2013
Q3 | $70K | Buy |
1,330
+1,089
| +452% | +$57.3K | ﹤0.01% | 2558 |
|
|
2013
Q2 | $13K | Buy |
+241
| New | +$13K | ﹤0.01% | 2675 |
|